Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Clariant AGXSWX:CLN +1.21%64 Days Sales Outstanding is 61.00 as of Jun. 2026, which is 4% above its 10-year median of 58.83. GuruFocus rates XSWX:CLN with a GF Score™ of 64/100 and a GF Value™ of CHF9.11 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 1,580 Chemicals companies, Clariant AG ranks better than 56.39% on this metric.
Clariant AG's average Accounts Receivable for the
six
months ended in Jun. 2026 was CHF622 Mil. Clariant AG's Revenue for the
six
months ended in Jun. 2026 was CHF1,859 Mil.
Hence, Clariant AG's Days Sales Outstanding for the
six
months ended in Jun. 2026 was 61.00.
The historical rank and industry rank for Clariant AG's Days Sales Outstanding or its related term are showing as below:
XSWX:CLN'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 51.05 Med: 58.83 Max: 89.63
Current: 58.47
During the past 13 years, Clariant AG's highest Days Sales Outstanding was 89.63. The lowest was 51.05. And the median was 58.83.
XSWX:CLN's Days Sales Outstanding is ranked better than 56.39% of 1580
companies
in the Chemicals industry
Industry Median: 64.71
vs XSWX:CLN: 58.47
Clariant AG's Days Sales Outstanding
increased
from Jun. 2025 (55.97) to Jun. 2026 (61.00).
Clariant AG (XSWX:CLN) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Clariant AG Days Sales Outstanding Related Terms
Clariant AG Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Clariant AG's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:CLN vs LIN, SHW, ECL: Days Sales Outstanding Comparison
For the Specialty Chemicals subindustry, Clariant AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clariant AG Days Sales Outstanding vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Clariant AG's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Clariant AG's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clariant AG (XSWX:CLN) has a Days Sales Outstanding of 61.00 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Clariant AG and its competitors. This is near median its historical median of 58.83. Over the past decade, Clariant AG's Days Sales Outstanding has ranged from 51.05 to 89.63. According to the industry distribution chart, Clariant AG ranks #689 out of 1580 companies in the Chemicals industry, placing it in the top 43.6%.
Is Clariant AG's Days Sales Outstanding too high?
Clariant AG's current Days Sales Outstanding of 61.00 is near median its 10-year median of 58.83. Over the past 10 years, this metric has ranged from a low of 51.05 to a high of 89.63. The Chemicals industry median Days Sales Outstanding is 64.71. Clariant AG's value of 61.00 is 5.7% below this industry median. Based on the distribution chart, Clariant AG ranks #689 out of 1580 companies in the Chemicals industry, which is above the industry midpoint. Overall, Clariant AG has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariant AG's Days Sales Outstanding compare to LIN and SHW?
According to the Chemicals industry distribution chart, Clariant AG ranks #689 out of 1580 companies for Days Sales Outstanding. This puts Clariant AG in the upper half of its industry. The industry median Days Sales Outstanding is 64.71. Clariant AG's value of 61.00 is 5.7% below this benchmark. Historically, Clariant AG's own Days Sales Outstanding has ranged from 51.05 to 89.63 over the past decade. While the company's 10-year median is 58.83 vs. the industry median of 64.71, Clariant AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Chemicals company?
The median Days Sales Outstanding among Chemicals companies is 64.71, based on 1,580 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clariant AG's current Days Sales Outstanding of 61.00 is 5.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Clariant AG and its competitors. For the Chemicals industry, the median Days Sales Outstanding is 64.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clariant AG's current Days Sales Outstanding is 61.00, which is near median its own 10-year median of 58.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariant AG stock overvalued right now?
Based on GuruFocus' analysis, Clariant AG (XSWX:CLN) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF9.11, compared to a current price of CHF10.83 — trading 18.9% above its estimated fair value. The current Days Sales Outstanding is 61.00, which is near median its 10-year median of 58.83 and 5.7% below the Chemicals industry median of 64.71. Clariant AG's overall GF Score™ is 64/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Clariant AG (XSWX:CLN), the current Days Sales Outstanding is 61.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clariant AG (XSWX:CLN) Overvalued in 2026?
Based on GuruFocus' analysis, Clariant AG stock appears to be overvalued.
The current stock price of CHF10.83 is trading 18.9% above its estimated GF Value™ of CHF9.11.
GuruFocus considers Clariant AG to be Modestly Overvalued.
Key valuation signals for XSWX:CLN:
Days Sales Outstanding: 61.00 (near median its 10-year median of 58.83)
GF Value™: CHF9.11 vs. price of CHF10.83 (18.9% above fair value)
Industry Position: 5.7% below the Chemicals median (#689 of 1580)
No single metric tells the full story. See the XSWX:CLN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clariant AG is a Switzerland-based specialty chemicals company with world-wide operations. It develops, manufactures, distributes, and sells a broad range of specialty chemicals, which play a key role in its customers' manufacturing and treatment processes or add value to their end products. The company reports in three business areas: care chemicals, absorbents and additives and catalysts. Care chemicals mainly targets consumer end markets such as personal care and homecare, but it also has an industrial component. Absorbents and additives encompass Clariant's coatings and adhesives, absorbents, and plastics segments. Catalysts manufacturers process catalysts, mainly for petrochemical and syngas plants.
64GF Score
Get the complete analysis for XSWX:CLN
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:CLN has been successfully added to your 
